Literature DB >> 8208549

Modulation of c-MET proto-oncogene (HGF receptor) mRNA abundance by cytokines and hormones: evidence for rapid decay of the 8 kb c-MET transcript.

A Moghul1, L Lin, A Beedle, A Kanbour-Shakir, M C DeFrances, Y Liu, R Zarnegar.   

Abstract

The c-MET proto-oncogene product is a transmembrane tyrosine kinase receptor which was recently shown to transmit an array of important cellular responses induced by Hepatocyte Growth Factor (HGF). These biological effects include induction of mitogenesis, motogenesis, morphogenesis, metastogenesis and anti-tumor activity on a variety of epithelial cells. All of these processes are known to be associated with normal and abnormal tissue growth and development. The 190 kDa c-MET protein is encoded by a major transcript of 8 kilobases (kb), which is reported to be expressed predominantly in epithelial tissues. The expression pattern of c-MET mRNA and protein are drastically modified in many tumor tissues and cell lines. Currently, no information is available on the molecular mechanisms that regulate c-MET mRNA level. In the present communication, we report for the first time that the inflammatory cytokines such as IL-1 alpha, IL-6 and TNF-alpha, as well as TGF-beta 1, EGF, HGF and the steroidal hormones (estrogen, progesterone, tamoxifen and dexamethasone) markedly influence the steady-state levels of the 8 kb c-MET mRNA in human carcinoma cell lines derived from human tissues such as ovary, breast and endometrium. We demonstrate that c-MET receptor protein is present at high levels in primary tumors of human ovaries (clear cell carcinomas). We present evidence that the 8 kb c-MET mRNA undergoes rapid degradation with a half-life of less than 30 min and that this decay can be quickly inhibited by cycloheximide. Our results suggest that the expression of the c-met proto-oncogene resembles that of an immediate early response gene.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8208549

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  31 in total

1.  Induction of c-met proto-oncogene expression at the metastatic site.

Authors:  J Imai; M Watanabe; M Sasaki; R Yamaguchi; S Tateyama; S Sugano
Journal:  Clin Exp Metastasis       Date:  1999-07       Impact factor: 5.150

2.  Role of HGF in obesity-associated tumorigenesis: C3(1)-TAg mice as a model for human basal-like breast cancer.

Authors:  Sneha Sundaram; Alex J Freemerman; Amy R Johnson; J Justin Milner; Kirk K McNaughton; Joseph A Galanko; Katharine M Bendt; David B Darr; Charles M Perou; Melissa A Troester; Liza Makowski
Journal:  Breast Cancer Res Treat       Date:  2013-11-12       Impact factor: 4.872

3.  Modulation of hepatocyte growth factor secretion in human female reproductive tract stromal fibroblasts by poly (I:C) and estradiol.

Authors:  Kimberly D Coleman; Mimi Ghosh; Sarah G Crist; Jacqueline A Wright; Richard M Rossoll; Charles R Wira; John V Fahey
Journal:  Am J Reprod Immunol       Date:  2011-08-23       Impact factor: 3.886

4.  A phase 1 study of the c-Met inhibitor, tivantinib (ARQ197) in children with relapsed or refractory solid tumors: A Children's Oncology Group study phase 1 and pilot consortium trial (ADVL1111).

Authors:  James I Geller; John P Perentesis; Xiaowei Liu; Charles G Minard; Rachel A Kudgus; Joel M Reid; Elizabeth Fox; Susan M Blaney; Brenda J Weigel
Journal:  Pediatr Blood Cancer       Date:  2017-04-27       Impact factor: 3.167

5.  SREBP Plays a Regulatory Role in LH/hCG Receptor mRNA Expression in Human Granulosa-Lutein Cells.

Authors:  Yin-Xia Li; Xingzi Guo; Thippeswamy Gulappa; Bindu Menon; K M J Menon
Journal:  J Clin Endocrinol Metab       Date:  2019-10-01       Impact factor: 5.958

6.  Comparison of c-met expression in ovarian epithelial tumors and normal epithelia of the female reproductive tract by quantitative laser scan microscopy.

Authors:  D Huntsman; J H Resau; E Klineberg; N Auersperg
Journal:  Am J Pathol       Date:  1999-08       Impact factor: 4.307

7.  Cross-talk between steroid-receptor-mediated and cell-membrane-receptor-mediated signalling pathways results in the in vivo modulation of c-Met and ornithine decarboxylase gene expression in mouse kidney.

Authors:  M Dudkowska; A Stachurska; W Chmurzyska; B Grzelakowska-Sztabert; M Manteuffel-Cymborowska
Journal:  Biochem J       Date:  2001-01-15       Impact factor: 3.857

Review 8.  MET as a target for treatment of chest tumors.

Authors:  Nicole A Cipriani; Oyewale O Abidoye; Everett Vokes; Ravi Salgia
Journal:  Lung Cancer       Date:  2008-07-30       Impact factor: 5.705

Review 9.  The role of MET receptor tyrosine kinase in non-small cell lung cancer and clinical development of targeted anti-MET agents.

Authors:  Kyle W Robinson; Alan B Sandler
Journal:  Oncologist       Date:  2013-01-23

10.  The Met protooncogene is a transcriptional target of NF kappaB: implications for cell survival.

Authors:  James Y Dai; Marie C DeFrances; Chunbin Zou; Carla J Johnson; Reza Zarnegar
Journal:  J Cell Biochem       Date:  2009-08-15       Impact factor: 4.429

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.